The US Department of Agriculture approved the genetically modified purple tomato to extend its shelf life and boost nutritional quality almost 15 years after its development.
According to biochemist Cathie Martin, she and her colleagues at Norfolk Plant Scientists (NPS) have been experimenting with pigment production in flowering plants for over two decades, and they've spent almost 15 months developing the purple tomato.
The NPS has been focusing on anthocyanins, the antioxidant-rich pigments that give blackberries and blueberries their signature shades.
Domesticated tomatoes already have genes to produce anthocyanins, but they are not 'turned on.' By carefully adding two genes, the tomatoes and juice become a rich source of antioxidants, because purple pigments are made in the whole tomato, not just the skins.
While there are already some purple-skinned tomatoes, their pigments mostly stop at the outer layers and don't accumulate in the fruit itself.
The NPS also emphasized that there is increasing evidence to show that antioxidants work much better when consumed within foods.
The USDA Animal and Plant Health Inspection Service (APHIS) reported that the tomato was modified to alter its color and enhance its nutritional quality, adding that the plant is unlikely to pose an increased plant pest risk compared to other cultivated tomatoes.
Nathan Pumplin, the CEO of NPS' US-based commercial business, said they are optimistic that they can begin limited distribution of purple tomatoes in the US by 2023.


Jared Isaacman Confirmed as NASA Administrator, Becomes 15th Leader of U.S. Space Agency
US Dollar Weakens as Iran Talks Boost Risk Appetite in Forex Market
Amazon Stock Rises as Meta Expands AWS Partnership for AI Infrastructure
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal
FDA Biologics Chief Vinay Prasad to Leave Agency in April Amid Policy Disputes
Gold Prices Rise Slightly but Head for Weekly Loss Amid Oil Surge and Inflation Fears
Dollar Gains as Middle East Tensions and Rising Oil Prices Support Safe-Haven Demand
Rising Jet Fuel Costs from Iran Conflict Push Airfare Higher Across Europe
U.S. Vaccine Policy Shifts Under RFK Jr. Create Uncertainty for Pharma and Investors
Brazil Blocks Prediction Market Platforms, Tightens Derivatives Trading Rules
Florida Investigates OpenAI and ChatGPT Over Alleged Role in FSU Shooting
Trump Signs Executive Order to Boost AI Research in Childhood Cancer
US and EU Strengthen Critical Minerals Partnership to Reduce China Dependence
Tesla Earnings Beat Expectations as EV Growth Holds Amid Robotics and AI Shift
$16B Michigan Data Center Project Boosts U.S. AI Infrastructure Expansion
Judge Dismisses Elon Musk’s Fraud Claims Against OpenAI, Trial to Proceed on Remaining Allegations 



